TRE-515 Appears to Block Immune Cell Attacks in Mouse Study
An experimental oral therapy called TRE-515 significantly reduced disease severity and the growth of the abnormal immune cells that drive multiple sclerosisĀ (MS) in two mouse models of the disease, a study found. Notably, the efficacy of Trethera Corp.ās potential treatment, administered either in a preventive or therapeutic…